
ZBH Stock Forecast & Price Target
ZBH Analyst Ratings
Bulls say
Zimmer Biomet Holdings is a leading company in the orthopedic reconstructive implants and surgical equipment market, with a leading share in the United States, Europe, and Japan. The company's recent acquisition of Biomet and focus on large joints and extremities, trauma, and sports medicine products make it well-positioned for future growth. While the first quarter performance may have raised some questions and caused confusion, the company's ongoing strategic initiatives, new product launches, and salesforce optimization efforts provide a positive long-term outlook. However, there are some concerns regarding possible competition, quarterly performance consistency, and the success of new product innovations. Overall, the company's strong fundamentals and ongoing transformation efforts support a positive outlook for growth and improved margins in the years ahead.
Bears say
Zimmer Biomet Holdings is facing multiple challenges that may impede its growth in the future, such as a decline in sales in the US for large joint recon products, labor strikes on the West Coast, and ongoing product rationalizations. The company also has significant international exposure, making it vulnerable to changing market dynamics and potential competition from new market entrants. Furthermore, the company's high level of leverage and focus on recon markets may make it difficult for ZBH to rebound in the event of a volume decline or continued pricing pressure.
This aggregate rating is based on analysts' research of Zimmer Biomet Hlds and is not a guaranteed prediction by Public.com or investment advice.
ZBH Analyst Forecast & Price Prediction
Start investing in ZBH
Order type
Buy in
Order amount
Est. shares
0 shares